Logo Logo Logo Logo Logo
  • Our Mission
  • About Us
    • Founders
    • Management
    • Board of directors
    • Scientific advisors
  • Pipeline
    • Pipeline-At-a-Glance
    • Our technology
    • Publications
  • Patients & Families
  • Partners
  • Media
    • News
    • Events
    • Press releases
  • Join Us
  • Contact Us
  • Our Mission
  • About Us
    • Founders
    • Management
    • Board of directors
    • Scientific advisors
  • Pipeline
    • Pipeline-At-a-Glance
    • Our technology
    • Publications
  • Patients & Families
  • Partners
  • Media
    • News
    • Events
    • Press releases
  • Join Us
  • Contact Us
 

Media Archive 2020

BACK TO MEDIA

News 2020

Date

News

27 jun 2020

Dai funghi ai microelettrodi. La carica delle 50 startup, Avvenire

22 jun 2020

Usiamo il virus HIV per curare col DNA le cellule malate, Il Giornale di Vicenza

02 apr 2020

Lettera aperta al Governo Italiano per sostenere le startup e PMI innovative, Corriere della Sera

feb 2020

Quando la cura siamo noi, BenEssere

17 jan 2020

Biotech, nascerà a San Francisco la casa delle start up italiane, Il Sole 24 Ore

11 jan 2020

Tutto pronto per la J.P.Morgan Healthcare di San Francisco: la più grande conferenza mondiale sul biotech, StartupItalia

08 jan 2020

Biotech italiano a San Francisco: Da Altheia a Wise, parte la missione delle start up alla conferenza mondiale JP Morgan, Corriere della Sera

ARCHIVE 2019

ARCHIVE 2018

ARCHIVE 2017

Events

Date

Events

15 jan 2020

Healthcare: Italy on the Move 2020

With the participation of Paolo Rizzardi, Chairman & CEO Altheia Science, to the panel “Why invest in Italian Life Sciences”.

More info

ARCHIVE 2019

ARCHIVE 2018

logo

Italy Office:
Via Conservatorio, 30
20122 Milano

US Office:
The Empire State Building
350 Fifth Avenue
Suite 7530
New York, NY 10118

© 2020 Altheia Science Srl
C.F. e P.IVA 10128260964 - Sede legale: Via Conservatorio, 30 - 20122 Milano (Italy)
N. iscrizione Reg. Imprese di Milano REA n. 2507510

Privacy Policy Cookie Policy